The Paul E. Lacy Lecture was established in 1987 to honor Paul E. Lacy, MD, PhD, professor emeritus and former Robert L. Kroc Professor of Pathology at Washington University School of Medicine. Dr. Lacy served as the Chairman of the Department of Pathology from 1960 until 1984. He is recognized worldwide as a leader in the study of the physiopathology of insulin-dependent diabetes mellitus.
Dr. Lacy and his associates have examined the basic cellular mechanisms of glucose-induced secretion of insulin. One of his outstanding contributions has been the use of islet transplants for the treatment of experimental diabetes. Aside from his extensive research accomplishments, Dr. Lacy has been an undisputed leader at Washington University School of Medicine, where he developed a distinguished department with excellence in many areas of biomedical research.
Dr. Lacy's emphasis on research as a component of pathology has had a major influence nationwide. Through his continuous counseling and direction, a large number of experimental pathologists have developed their expertise at Washington University, and many of them have subsequently left to create their own departments.
The Lacy Lecture is partially supported with funds from the Kilo Diabetes and Vascular Research Foundation. The Kilo Foundation has a major interest in diabetes and vascular research and supports research in the Department of Pathology and Immunology at Washington University School of Medicine.
Lecturers
|
| 2008 | Robert A. Weinberg, Ph.D., Member Whitehead Institute for Biomedical Research, Professor of Biology, MIT, Director, MIT Ludwig Center for Molecular Oncology |
| 2006 | Tasuku Honjo, MD, PhD Kyoto University, Kyoto, Japan |
| 2005 | Stephen C. Harrison, PhD Director, Center for Molecular and Cellular Dynamics, Harvard Medical School Boston, Massachusetts |
| 2004 | Klas Karre, MD, PhD Karolinska Institute, Microbiology & Tumor Biology Center Stockholm, Sweden |
| 2003 | Pamela Bjorkman, PhD California Institute of Technology Pasadena, California |
| 2002 | Anthony J. Pawson, PhD Samuel Lunenfeld Research Institute Mt. Sinai Hospital Toronto, Canada |
| 2001 | Federick W. Alt, PhD Harvard Medical School Boston, MA |
| 2000 | Robert Tjian, PhD University of California Berkeley, California |
| 1999 | James E. Darnell, Jr., MD. Head, Laboratory of Molecular Cell Biology Rockefeller University, New York |
| 1998 | Klaus Rajewsky, MD University of Cologne Cologne, Germany |
| 1997 | Andrew H. Wyllie, MD, ChB, PhD Department of Pathology University of Edinburgh Edinburgh, Scotland |
| 1996 | Judah Folkman, MD Department of Pediatric Surgery Harvard Medical School Boston, Massachusetts |
| 1995 | George Klein, MD Karolinska Institute Stockholm, Sweden |
| 1994 | Sir Gustav J.V. Nossal, MP, PhD Walter and Eliza Hall Institute of Medical Research Melbourne, Australia |
| 1992 | Hugh O. McDevitt, MD Department of Microbiology and Immunology Stanford University School of Medicine Stanford, California |
| 1991 | Barry R. Bloom, PhD Department of Microbiology and Immunology Albert Einstein College of Medicine Bronx, New York |
| 1990 | Jack L. Strominger, MD Department of Biochemistry and Molecular Biology Harvard University Boston, Massachusetts |
| 1989 | Russell Ross, PhD Department of Pathology University of Washington School of Medicine Seattle, Washington |
| 1988 | Ramzi C. Cotran, MD Department of Pathology Harvard Medical School Boston, Massachusetts |
| 1987 | George E. Palade, MD Department of Cell Biology Yale University New Haven, Connecticut |